Clinically actionable genotypes among 10,000 patients with preemptive pharmacogenomic testing

Since September 2010, over 10,000 patients have undergone preemptive, panel-based pharmacogenomic testing through the Vanderbilt Pharmacogenomic Resource for Enhanced Decisions in Care and Treatment (PREDICT) program. Analysis of the genetic data from the first 9,589 individuals reveals the frequenc...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Van Driest, Sara L., Shi, Yaping, Bowton, Erica A., Schildcrout, Jonathan S., Peterson, Josh F., Pulley, Jill, Denny, Josh C., Roden, Dan M.
Format: Artigo
Idioma:Inglês
Publicat: 2013
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3961508/
https://ncbi.nlm.nih.gov/pubmed/24253661
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/clpt.2013.229
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars